On the evening of February 3rd, in conjunction with Breakthrough Cancer Research and Boston Scientific, Tyndall National Institute will host a free event, open to the public, from 6-9pm. Registration is required due to limited space. Register here.
The event will showcase exemplars of recent progress as well as emerging HealthTech solutions in the diagnosis and treatment of cancer. Perspectives from clinicians, industry, scientists, and patients will be shared during the event and will include presentations and an interactive panel discussion.
The event is part of an annual pan-European initiative highlighting the impact of new and emerging health technologies in the fight against cancer. Similar events will take place in several cities across Europe with support from the H2020 NOBEL Project of which Tyndall is a partner.
- Ireland (Cork, Tyndall National Institute)
- France (Villejuif, Sup’biotech and ETPN)
- Israel (Tel-Aviv Yafo, Tel-Aviv University)
- Portugal (Braga, International Iberian Nanotechnology Laboratory (INL))
- Spain (Barcelona, Nanomed Spain and IBEC Barcelona)
NOBEL is supporting the creation of an integrated ecosystem within the EU, to accelerate the development and translation of nanomedicine and emerging medical technologies to ensure better clinical outcomes.
Across Europe during HealthTech World Cancer Day 2020 (WCD2020), leading experts of emerging medical technologies will share their knowledge and experience. These experts will focus on how HealthTech will provide solutions for the diagnosis and treatment of cancer. Cancer is still the second leading cause of death worldwide. In Ireland the number of cancer cases is increasing. Current estimates suggest that 1 in 2 people will be affected by cancer in Ireland during their lifetime. The number of cancer survivors is also increasing -190,000 or 4% of the population in Ireland are cancer survivors.